PharmaBoardroom

Swiss Pharma: Staying the Course

This article forms part of Healthcare & Life Sciences Review: Switzerland February 2021, a comprehensive up-to-date country report on the Swiss…

Brian O’Callaghan – CEO, ObsEva

Biotech veteran Brian O’Callaghan introduces ObsEva – a Swiss-based firm focused on women’s health –, his motivations to join the company –…

Nicolas Fischer – CEO, Light Chain Bioscience

Dr Nicolas Fischer introduces Light Chain Bioscience, a Swiss biotech company focusing on the discovery and development of bispecific antibodies using…

Alessandro Riva – CEO, Ichnos Sciences

Alessandro Riva, MD joined biotech Ichnos Sciences as its founding CEO in 2019, leaving behind a storied career in oncology R&D at Novartis and…

China: AstraZeneca/Junshi anti-PD-1 Tie-Up; New UK Biologics Plan…

The latest from Chinese pharma, including a new deal between AstraZeneca and Junshi Biosciences; Innoforce and dMed’s R&D collab; and investment…

Carl Firth – CEO, ASLAN Pharmaceuticals

ASLAN Pharmaceuticals is a clinical-stage immunology-focused biopharmaceutical company. CEO Dr Carl Firth reveals why the company has shifted its…

China: Yangtze River Pharmaceutical Group (YRPG) in Profile

One of the largest domestic pharma companies in China (ranking number one from 2014 to 2019), Yangtze River Pharmaceutical Group (YRPG) is so-named…

5 US Rare Disease Start-Ups to Watch

Following on from our profile on five of the most promising clinical-stage biotech companies developing orphan therapies in Europe, here we move to…

HiFiBiO CEO on the Keys to Global Biotech Success

HiFiBiO Therapeutics cofounder, CEO and CSO Dr Liang Schweizer fits the profile of a Chinese biotech CEO to a T: advanced degrees in different…

Liang Schweizer – CEO & CSO, HiFiBiO Therapeutics

Dr Liang Schweizer introduces immunotherapy-focused biotech HiFiBiO Therapeutics, the main advantages of the company’s unique single-cell technology…

5 European Rare Disease Start-Ups to Watch

With Rare Disease Day falling on 28 February, PharmaBoardroom dedicates this month to exploring the global rare disease landscape, highlighting key…

Chris Martin – CEO, Co-Founder and Director, ADC…

Dr Chris Martin, CEO and co-founder of Swiss-headquartered antibody-drug conjugate cancer company, ADC Therapeutics, shares the company’s journey…

Tagged with Biotech,